Pancreatic Cancer News
In a survey of more than 1000 adults, 83% said they are unaware of the signs or symptoms of pancreatic cancer.
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Bariatric surgery may reduce the risk of pancreatic cancer in patients with obesity who are younger than 50 years of age, a study suggests.
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Delivery of radiation to the celiac plexus can decrease pain and opioid use among patients with pancreatic cancer, a phase 2 study suggests.
A diagnosis of PCOS was associated with a 1.9-fold higher risk of pancreatic cancer in a case-control study.
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
The gene sequencing panel PancreaSeq can accurately classify pancreatic cysts as benign or potentially cancerous, according to researchers.
A retrospective evaluation of lab results linked the likelihood of certain cancer types with the presence of specific pathogenic variants in CHEK2.
A team of investigators identified prognostic genomic markers in patients with metastatic or locally advanced pancreatic ductal adenocarcinoma.
The deep learning-based tool distinguished between malignancy and controls with high sensitivity and specificity.
Adding liposomal irinotecan to 5-fluorouracil and leucovorin can improve outcomes in gemcitabine-refractory, advanced pancreatic cancer, a phase 3 study suggests.
Sugar-sweetened beverage consumption is associated with increased mortality for colorectal and kidney cancers, even after adjustment for BMI.
177Lutetium-octreotate can improve progression-free survival vs sunitinib in patients with progressive pancreatic neuroendocrine tumors.
Preoperative FDG-PET may predict pathologic response to neoadjuvant therapy for borderline resectable/locally advanced PDAC.
SY-5609 is currently being evaluated in combination with chemotherapy in a phase 1 trial.
Adjuvant mFOLFIRINOX improved disease-free survival, cancer-specific survival, and overall survival at 5 years.
Researchers found that 30% of pancreatic adenocarcinoma trials completed from 2010 through 2020 did not have results available.
Men tend to have a higher risk of cancer than women, and factors such as smoking, alcohol use, and diet do not appear to explain this disparity.
In a cohort of privately-insured patients, the median out-of-pocket cost for genetic counseling was $0.